166 filings
Page 4 of 9
6-K
VALN
Valneva SE
29 Sep 22
Valneva Announces Launch of Approximately $40 Million in a Proposed Global Offering of American Depositary Shares and Ordinary Shares
7:36am
424B5
VALN
Valneva SE
28 Sep 22
Prospectus supplement for primary offering
8:24pm
6-K
VALN
Valneva SE
26 Sep 22
Valneva Provides Further Update on its COVID-19 Activities
4:30pm
6-K
VALN
Valneva SE
20 Sep 22
Valneva and IDT Biologika Agree on Termination of their COVID-19 Collaboration
1:00pm
6-K
VALN
Valneva SE
8 Sep 22
Valneva Announces Publication of its COVID-19 Vaccine Phase 3 Data in The Lancet Infectious Diseases
3:39pm
6-K
VALN
Valneva SE
29 Aug 22
Current report (foreign)
5:00pm
6-K
VALN
Valneva SE
26 Aug 22
Valneva Confirms WHO Recommendations for its Inactivated COVID-19 Vaccine
5:00pm
EFFECT
VALN
Valneva SE
22 Aug 22
Notice of effectiveness
12:15am
6-K
VALN
Valneva SE
19 Aug 22
Valneva Provides Update on IXIARO® Supply Contract with U.S. Department of Defense
5:00pm
CORRESP
VALN
Valneva SE
17 Aug 22
Correspondence with SEC
12:00am
UPLOAD
VALN
Valneva SE
16 Aug 22
Letter from SEC
12:00am
6-K
VALN
Valneva SE
15 Aug 22
Report of Foreign Private Issuer
9:20am
F-3
VALN
Valneva SE
12 Aug 22
Shelf registration (foreign)
4:42pm
6-K/A
VALN
Valneva SE
11 Aug 22
Current report (foreign) (amended)
5:55pm
6-K
VALN
Valneva SE
11 Aug 22
Valneva Reports H1 2022 Results and Provides Corporate Updates
5:47pm
6-K
VALN
Valneva SE
9 Aug 22
Current report (foreign)
12:00am
6-K
VALN
Valneva SE
3 Aug 22
Valneva Confirms Amendment of Advance Purchase Agreement with European Commission for Valneva’s Inactivated COVID-19 Vaccine
1:26pm
6-K
VALN
Valneva SE
20 Jul 22
European Commission Approves Purchase Agreement Amendment for Valneva’s Inactivated COVID-19 Vaccine
12:45pm
SC 13G
VALN
Valneva SE
29 Jun 22
Valneva SE / PFIZER ownership change
5:09pm
6-K
VALN
Valneva SE
24 Jun 22
Valneva Announces Successful Outcome of its AGM and Appointment of two New Supervisory Board Members
1:30pm